Last update: July 2, 2015
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Tigecycline in other languages or writings:
Main tradenames from several countries containing Tigecycline in its composition:
Write to us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche de México from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
On latest update no relevant data related to breastfeeding were found.
Pharmacokinetic data (wide distribution volume, moderately high molecular weight and high protein binding) suggest that excretion into breast milk would not be significant.
Even more, low oral bioavailability makes absorption from ingested breast milk into infant’s blood be nil or scanty. However, in premature infants and neonates in early postpartum, blood levels are likely higher due to increased gut absorption.
Nonetheless, a safer alternative with other known antibiotic is preferred until more information is available.